Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Rapid evolution may have helped bats avoid cancer, study finds
The researchers sequenced the genomes of the Jamaican fruit bat (pictured) and the Mesoamerican mustached bat.

It may also help them tolerate viruses.
 

A study has suggested that rapid evolution may be the reason why bats are able to avoid cancer, and also tolerate viral infections like SARS-CoV-2.

The researchers aimed to investigate bats’ low cancer rates and robust immune system, with the theory that it may have implications for human health. For example, performing comparative genomic analysis of bats against mammals that are susceptible to cancer may lead to new discoveries on the causes of cancer, and its links with immunity.

It could also further our understanding of why bats are tolerant to zoonotic viruses, such as SARS-CoV-2, before they get passed onto humans. This could lead to work that may better prevent disease outbreaks from animals to people.

The investigation involved the researchers using the Oxford Nanopores Technologies long-read platform to sequence the genomes of two bat species, the Jamaican fruit bat and the Mesoamerican mustached bat, which have key evolutionary positions.

They then conducted a comparative genomic analysis with a diverse collection of bats and other mammals.

This found genetic adaptations in six DNA repair-related proteins and 46 proteins in bats that were cancer-related. It revealed that these altered cancer-related genes were twice as enriched in the bats compared to other mammals.

The analysis identified antiviral genes that showed evidence of rapid evolution. There were also positive selection signs in 33 tumour suppressors and 6 DNA-repair genes which may contribute to bats’ increased longevity and reduced cancer rates.

This shows that the immune systems of bats rely on bat-wide and lineage-specific evolution among their genes, which suggests diverse immune strategies.

Armin Scheben, the lead author, said: “By generating these new bat genomes and comparing them to other mammals we continue to find extraordinary new adaptations in antiviral and anticancer genes,

“These investigations are the first step towards translating research on the unique biology of bats into insights relevant to understanding and treating aging and diseases, such as cancer, in humans.”

The full study can be found in the Genome Biology and Evolution journal.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

NOAH board elected

News Story 1
 NOAH has elected its board team, as part of its annual general meeting.

Ned Flaxman, general manager at Norbrook Laboratories Ltd, retains his position as chair, which he has held since June 2023.

Caitrina Oakes (Vetoquinol) remains past chair, and Matthew Frost (Elanco) remains treasurer.

Andrew Buglass (Eco Animal Health Ltd), Oya Canbas (Zoetis) and Charlotte Covell (Virbac) are newly elected vice-chairs. Meanwhile Roy Geary (Ceva) and John Toole (Beaphar) join the NOAH Board of Management.

Dawn Howard, NOAH chief executive, said: "I congratulate all the officers and board members who have been elected or re-elected today.

"I look forward to working together to ensure that NOAH continues to deliver at the highest standard for its members." 

Click here for more...
News Shorts
Series two of SCOPS podcast launched

The Sustainable Control of Parasites in Sheep (SCOPS) Group has launched the second series of its podcast.

The series will comprise four episodes, with topics including the sustainable use of parasite treatments, effective quarantining, administrating a mid/late season dose, and tackling resistance to multiple groups of anthelmintic.

Kevin Harrison, Gloucestershire sheep farmer and SCOPS chair, said: "The podcast is suitable for sheep farmers, vets and advisers, so please subscribe and spread the word if you enjoy the content.

"All episodes from series one are still available online, as well as the new episodes being added."

The podcast is available on the SCOPS website and other podcast platforms.